InSysBio announces its participation in AACR Annual Meeting 2025 which is to be held from April 25-30, 2025, at McCormick Place Convention Center, Chicago, Illinois, USA. InSysBio team is going to present their QSP modeling services and software to optimize drug development at Booth #4845 and 3 posters in frames of the Meeting, namely:

Monday, April 28, 09:00 AM - 12:00 PM ET:

Location: Poster Section 34, Poster Board Number: 16

• 2130 "Optimization of tarlatamab step-up dosing regimen to mitigate cytokine release syndrome using quantitative systems pharmacology modeling" by Oleg Demin Jr, Galina Kolesova, Dmitry Shchelokov

Monday, April 28, 02:00 PM - 05:00 PM ET:

Location: Poster Section 28, Poster Board Number: 15

• 3219 "Assessing strategies to activate DNAM1 signaling and inhibit the TIGIT/PVRIG axis using mathematical modeling" by Oleg Demin Jr, Galina Kolesova, Dmitry Shchelokov

Wednesday, April 30, 09:00 AM - 12:00 PM ET:

Location: Poster Section 38, Poster Board Number: 7

• 7260 "Predicting the starting dose and step-up regimen for first-in-human trial of T-cell engagers using mechanistic mathematical modeling" by Oleg Demin Jr, Galina Kolesova, Dmitry Shchelokov

Check out Booth #4845 and posters at AACR Annual Meeting 2025!

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com

Share